Feds, Nobel Prize Winner Back Sanofi At High Court IP Fight

By Dani Kass (February 13, 2023, 11:01 PM EST) -- The federal government, various drug companies and a molecular biologist who won the Nobel Prize for his work with monoclonal antibodies urged the U.S. Supreme Court to keep the standard of patent enablement as is, backing Sanofi and Regeneron in their fight against Amgen....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!